http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 04 Aug 2026 06:55:03 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Fulgent+Genetics+%28FLGT%29+PT+Raised+to+%2419+at+Piper+Sandler/26861157.html Piper Sandler analyst David Westenberg raised the price target on Fulgent Genetics (NASDAQ: FLGT) to $19.00 (from $15.00) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/Fulgent+Genetics+%28FLGT%29+PT+Raised+to+%2419+at+Piper+Sandler/26861157.html Tue, 04 Aug 2026 06:55:03 -0400 FLGT http://www.streetinsider.com/Earnings/Fulgent+Genetics%2C+Inc.+%28FLGT%29+Misses+Q2+EPS+by+14c+%3B+Offers+Guidance/26843902.html <p>Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of ($0.58), $0.14 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $85.4 million versus the consensus estimate of $91.77 million.</p><p><strong>GUIDANCE:</strong></p><p>Fulgent Genetics, Inc. sees FY2026 EPS of ($2.22)-($2.35), versus the consensus of ($1.55). Fulgent Genetics, Inc. sees FY2026 revenue of $330-340 million, versus the consensus of $352.2 million.</p><p>For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) <a href="http://www.streetinsider.com/ec_earnings.php?q=FLGT">click here</a>.</p> http://www.streetinsider.com/Earnings/Fulgent+Genetics%2C+Inc.+%28FLGT%29+Misses+Q2+EPS+by+14c+%3B+Offers+Guidance/26843902.html Thu, 30 Jul 2026 16:18:22 -0400 FLGT http://www.streetinsider.com/Guidance/Fulgent+Genetics%2C+Inc.+%28FLGT%29+Misses+Q2+EPS+by+14c+%3B+Offers+Guidance/26843902.html <p>Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of ($0.58), $0.14 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $85.4 million versus the consensus estimate of $91.77 million.</p><p><strong>GUIDANCE:</strong></p><p>Fulgent Genetics, Inc. sees FY2026 EPS of ($2.22)-($2.35), versus the consensus of ($1.55). Fulgent Genetics, Inc. sees FY2026 revenue of $330-340 million, versus the consensus of $352.2 million.</p><p>For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) <a href="http://www.streetinsider.com/ec_earnings.php?q=FLGT">click here</a>.</p> http://www.streetinsider.com/Guidance/Fulgent+Genetics%2C+Inc.+%28FLGT%29+Misses+Q2+EPS+by+14c+%3B+Offers+Guidance/26843902.html Thu, 30 Jul 2026 16:18:22 -0400 FLGT http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jun+30/26843744.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260730/AK2V422FZM2RU2ZU222H2CYMBCASZZ22Z282">http://archive.fast-edgar.com/20260730/AK2V422FZM2RU2ZU222H2CYMBCASZZ22Z282</a></p> <p> Filed on: July 30, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jun+30/26843744.html Thu, 30 Jul 2026 16:13:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jun+30/26843744.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260730/AK2V422FZM2RU2ZU222H2CYMBCASZZ22Z282">http://archive.fast-edgar.com/20260730/AK2V422FZM2RU2ZU222H2CYMBCASZZ22Z282</a></p> <p> Filed on: July 30, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jun+30/26843744.html Thu, 30 Jul 2026 16:13:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+30/26843659.html si-local-file:///var/storage/secattach/20260730/26843659.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+30/26843659.html Thu, 30 Jul 2026 16:10:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+30/26843659.html si-local-file:///var/storage/secattach/20260730/26843659.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+30/26843659.html Thu, 30 Jul 2026 16:10:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Press+Releases/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html <ul class="bwlistdisc"> <li> Revenue of $85.4 million, growing 20.1% sequentially </li> <li> GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-GAAP gross margin of 31.3% </li> <li> GAAP loss of $29.5 million, or $(1.05) per share; Non-GAAP loss of $16.2 million, or $(0.58) per share </li> <li> Executed on stock repurchase program; purchased approximately 1.5 million shares in the second quarter of 2026 totaling $23.8 million in cash </li> <li> Ended the second quarter of 2026 with $551.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.1 million </li> <li> Revised annual revenue guidance to http://www.streetinsider.com/Business+Wire/Fulgent+Reports+Second+Quarter+2026+Financial+Results/26843467.html Thu, 30 Jul 2026 16:05:00 -0400 A.50216726 FLGT O.21612337 O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Xie+Jian/26827674.html si-local-file:///var/storage/secattach/20260728/26827674.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Xie+Jian/26827674.html Tue, 28 Jul 2026 16:32:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Xie+Jian/26827674.html si-local-file:///var/storage/secattach/20260728/26827674.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Xie+Jian/26827674.html Tue, 28 Jul 2026 16:32:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Gao+Hanlin/26827679.html si-local-file:///var/storage/secattach/20260728/26827679.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Gao+Hanlin/26827679.html Tue, 28 Jul 2026 16:32:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Gao+Hanlin/26827679.html si-local-file:///var/storage/secattach/20260728/26827679.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Gao+Hanlin/26827679.html Tue, 28 Jul 2026 16:32:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Kim+Paul/26827682.html si-local-file:///var/storage/secattach/20260728/26827682.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Kim+Paul/26827682.html Tue, 28 Jul 2026 16:32:00 -0400 FLGT O.30099225 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Kim+Paul/26827682.html si-local-file:///var/storage/secattach/20260728/26827682.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Fulgent+Genetics%2C+Inc.++++For%3A+Jul+26++Filed+by%3A+Kim+Paul/26827682.html Tue, 28 Jul 2026 16:32:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html <p> EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2026 financial results after the market closes on Thursday, July 30, 2026. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions. </p><p> The call may be accessed through a live audio webcast on the Investor Relations section of the Company’s website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.fulgentgenetics.com&amp;esheet=54568091&amp;newsitemid=20260709923437&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.fulgentgenetics.com&amp;index=1&amp;md5=8153d5de1d21cc4e395a20a4e7e51983" http://www.streetinsider.com/Press+Releases/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html Thu, 09 Jul 2026 16:05:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Press+Releases/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html <p> EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2026 financial results after the market closes on Thursday, July 30, 2026. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions. </p><p> The call may be accessed through a live audio webcast on the Investor Relations section of the Company’s website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.fulgentgenetics.com&amp;esheet=54568091&amp;newsitemid=20260709923437&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.fulgentgenetics.com&amp;index=1&amp;md5=8153d5de1d21cc4e395a20a4e7e51983" http://www.streetinsider.com/Press+Releases/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html Thu, 09 Jul 2026 16:05:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Business+Wire/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html <p> EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2026 financial results after the market closes on Thursday, July 30, 2026. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions. </p><p> The call may be accessed through a live audio webcast on the Investor Relations section of the Company’s website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.fulgentgenetics.com&amp;esheet=54568091&amp;newsitemid=20260709923437&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.fulgentgenetics.com&amp;index=1&amp;md5=8153d5de1d21cc4e395a20a4e7e51983" http://www.streetinsider.com/Business+Wire/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html Thu, 09 Jul 2026 16:05:00 -0400 FLGT O.30099225 http://www.streetinsider.com/Business+Wire/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html <p> EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2026 financial results after the market closes on Thursday, July 30, 2026. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions. </p><p> The call may be accessed through a live audio webcast on the Investor Relations section of the Company’s website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.fulgentgenetics.com&amp;esheet=54568091&amp;newsitemid=20260709923437&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.fulgentgenetics.com&amp;index=1&amp;md5=8153d5de1d21cc4e395a20a4e7e51983" http://www.streetinsider.com/Business+Wire/Fulgent+to+Announce+Second+Quarter+2026+Financial+Results+on+Thursday%2C+July+30%2C+2026/26753198.html Thu, 09 Jul 2026 16:05:00 -0400 FLGT O.30099225